↓ Skip to main content

American Association for Cancer Research

U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review

Overview of attention for article published in Clinical Cancer Research, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
204 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
48 Mendeley
Title
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review
Published in
Clinical Cancer Research, October 2021
DOI 10.1158/1078-0432.ccr-21-2600
Pubmed ID
Authors

Shaily Arora, Preeti Narayan, Christy L. Osgood, Suparna Wedam, Tatiana M. Prowell, Jennifer J. Gao, Mirat Shah, Danielle Krol, Sakar Wahby, Melanie Royce, Soma Ghosh, Reena Philip, Gwynn Ison, Tara Berman, Christina Brus, Erik W. Bloomquist, Mallorie H. Fiero, Shenghui Tang, Richard Pazdur, Amna Ibrahim, Laleh Amiri-Kordestani, Julia A. Beaver

X Demographics

X Demographics

The data shown below were collected from the profiles of 204 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 10%
Researcher 4 8%
Student > Bachelor 2 4%
Other 2 4%
Student > Postgraduate 2 4%
Other 6 13%
Unknown 27 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 15%
Medicine and Dentistry 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Agricultural and Biological Sciences 2 4%
Chemistry 1 2%
Other 1 2%
Unknown 28 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 131. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2022.
All research outputs
#322,881
of 25,756,531 outputs
Outputs from Clinical Cancer Research
#140
of 13,307 outputs
Outputs of similar age
#8,170
of 444,774 outputs
Outputs of similar age from Clinical Cancer Research
#6
of 101 outputs
Altmetric has tracked 25,756,531 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,774 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.